![Patrick Machado](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick Machado
Vorsitzender bei
ADVERUM BIOTECHNOLOGIES, INC.
Vermögen: 2 Mio $ am 31.07.2026
Profil
Patrick Machado founded Medivation, Inc. in 1995, where he worked as Director from 2014 to 2016 and Medivation LLC (California) in 1995, where he worked as Director from 2014 to 2016.
Mr. Machado also currently works at Adverum Biotechnologies, Inc., as Chairman from 2019, Prota Therapeutics Pty Ltd., as Chairman, Xenon Pharmaceuticals, Inc., as Independent Director from 2020, and various other companies.
Mr. Machado also formerly worked at Armaron Bio Ltd., as Chairman, Inotek Pharmaceuticals Corp., as Independent Director from 2016 to 2018, ACELYRIN, Inc., as Independent Director from 2021 to 2025, and various other companies.
Mr. Machado received his undergraduate degree in 1986 from Santa Clara University and graduate degree in 1989 from Harvard Law School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ARCUS BIOSCIENCES, INC. 0,04 % | 11.06.2026 | 44 300 ( 0,04 % ) | 1 Mio $ | 31.07.2026 |
ALUMIS INC. 0,01 % | 30.06.2026 | 10 617 ( 0,01 % ) | 299 930 $ | 31.07.2026 |
| 03.06.2026 | 0 ( -.--% ) | - $ | 31.07.2026 |
Aktive Positionen von Patrick Machado
| Unternehmen | Position | Beginn |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Vorsitzender | 01.05.2019 |
| ARCUS BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 10.12.2019 |
| XENON PHARMACEUTICALS INC. | Direktor/Vorstandsmitglied | 05.11.2020 |
| ALUMIS INC. | Direktor/Vorstandsmitglied | 01.06.2024 |
ProTA Therapeutics Pty Ltd.
 ProTA Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorsitzender | - |
Auransa, Inc.
 Auransa, Inc. BiotechnologyHealth Technology Operates as a computational pharmaceutical company | Direktor/Vorstandsmitglied | - |
Avenzo Therapeutics, Inc.
 Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Patrick Machado
| Unternehmen | Position | Ende |
|---|---|---|
| ACELYRIN, INC. | Direktor/Vorstandsmitglied | 21.05.2025 |
| CHIMERIX, INC. | Direktor/Vorstandsmitglied | 20.06.2024 |
| ░░░░░░░░░ ░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Patrick Machado
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
55
Beziehungen ersten Grades
33
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 33 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Orion Acquisition Corp. II
 Orion Acquisition Corp. II Financial ConglomeratesFinance Development stage company | Finance |
Cytyc Corp.
 Cytyc Corp. Medical SpecialtiesHealth Technology Manufactures and markets medical diagnostic applications | Health Technology |
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
Inotek Pharmaceuticals Corp.
 Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Engages in the development, discovery and commercialization of therapies for glaucoma and other diseases of the eye | Health Technology |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage structure based drug design company for cancer diseases | Health Technology |
Roivant Sciences Ltd.
 Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
Morrison & Foerster LLP
 Morrison & Foerster LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Xenon Pharmaceuticals, Inc.
 Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
Pro-Duct Health, Inc.
 Pro-Duct Health, Inc. Medical SpecialtiesHealth Technology Develops medical products for the evaluation of breast cancer | Health Technology |
SCYNEXIS, Inc.
 SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
Medivation, Inc. /Old/
 Medivation, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Santa Clara University
 Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer and inflammatory diseases | Health Technology |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
Medivation Neurology LLC
 Medivation Neurology LLC BiotechnologyHealth Technology Develops and produces biopharmaceutical products | Health Technology |
Armaron Bio Ltd.
 Armaron Bio Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops cardioprotection and neuroprotection small molecules to reduce tissue damage for heart attacks | Electronic Technology |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops gene therapies | Health Technology |
Harvard Law School
 Harvard Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops gene therapies to treat neurodegenerative diseases | Health Technology |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Auransa, Inc.
Auransa, Inc. BiotechnologyHealth Technology Operates as a computational pharmaceutical company | Health Technology |
ProTA Therapeutics Pty Ltd.
ProTA Therapeutics Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Therachon Holding GmbH
 Therachon Holding GmbH BiotechnologyHealth Technology Develops medical treatments for rare conditions | Health Technology |
Turnstone Biologics Corp.
 Turnstone Biologics Corp. BiotechnologyHealth Technology Develops and sells medicines to treat and cure solid tumors | Health Technology |
Therachon AG | |
Montes Archimedes Acquisition Corp.
 Montes Archimedes Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
ACELYRIN, Inc.
 ACELYRIN, Inc. Pharmaceuticals: MajorHealth Technology Operates as late-stage clinical biopharmaceutical company which focuses on identifying, acquiring and accelerating the development & commercialization of medicines | Health Technology |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of medicines for autoimmune disorders | Health Technology |
Avenzo Therapeutics, Inc.
Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Health Technology |
